Trial
NCT05300958
Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Triple Negative Breast Cancer
Intervention
Deferoxamine Plus Chemotherapy
Why stopped
Difficulty accruing subjects the study accrual was closed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-22